| Literature DB >> 22021757 |
Danilo F Santaella1, Cesar R S Devesa, Marcos R Rojo, Marcelo B P Amato, Luciano F Drager, Karina R Casali, Nicola Montano, Geraldo Lorenzi-Filho.
Abstract
OBJECTIVES: Since ageing is associated with a decline in pulmonary function, heart rate variability and spontaneous baroreflex, and recent studies suggest that yoga respiratory exercises may improve respiratory and cardiovascular function, we hypothesised that yoga respiratory training may improve respiratory function and cardiac autonomic modulation in healthy elderly subjects.Entities:
Year: 2011 PMID: 22021757 PMCID: PMC3191432 DOI: 10.1136/bmjopen-2011-000085
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flowchart of study recruitment.
Demographic and biochemical characteristics of the population according to the assigned intervention
| Control (n=14) | Yoga (n=15) | p Value | |
| Anthropometric data | |||
| Female, n | 10 | 09 | |
| Age, years | 69±7 | 68±4 | 0.631 |
| Body mass index, kg/m2 | 25±3 | 24±3 | 0.336 |
| Cardiovascular data | |||
| Heart rate, bpm | 65±7 | 64±10 | 0.265 |
| Systolic blood pressure, mm Hg | 130±11 | 131±12 | 0.974 |
| Diastolic blood pressure, mm Hg | 78±7 | 85±12 | 0.103 |
| Biochemical analysis | |||
| Total cholesterol, mg/dl | 197±41 | 202±27 | 0.887 |
| Low density lipoprotein, mg/dl | 108±38 | 115±25 | 0.636 |
| High density lipoprotein, mg/dl | 57±8 | 55±9 | 0.619 |
| Triglycerides, mg/dl | 119±47 | 119±39 | 0.411 |
| Blood glucose, mg/dl | 99±18 | 90±10 | 0.149 |
| Creatinine, mg/dl | 1.0±0.2 | 0.9±0.3 | 0.531 |
| Thyroid stimulating hormone, mU/ml | 3.2±2.3 | 3.7±6.8 | 0.881 |
Data are means±SD.
Spirometric variables at baseline and after 4 months for the control and yoga groups
| Variables | Control (n=14) | Yoga (n=15) | ||||
| Baseline | 4 Months | p Value | Baseline | 4 Months | p Value | |
| FVC, litres | 3.2±0.6 | 3.1±0.6 | 0.2 | 3.2±0.8 | 3.3±0.8 | 0.005 |
| FEV1, litres | 2.4±0.4 | 2.4±0.4 | 0.6 | 2.3±0.6 | 2.4±0.6 | 0.005 |
| FEF25–75, l/s | 2.1±0.6 | 2.2±0.7 | 0.8 | 1.8±0.7 | 1.9±0.5 | 0.7 |
| PEFR, l/s | 6.5±1.9 | 5.8±2.0 | 0.09 | 6.0±2.2 | 6.3±2.0 | 0.3 |
Data are expressed as means±SD.
FEF25–75, forced expiratory flow from 25% to 75% of FVC; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PEFR, peak expiratory flow rate.
Figure 2Individual values for maximum expiratory power (PEmax) and maximum inspiratory power (PImax). There were no significant differences at baseline between groups for both variables. The yoga group showed significant increases in PEmax and PImax at 4 months. The difference between groups became significant for PEmax at 4 months. Data are expressed as means±SD.
Figure 3Individual values for sympathovagal balance (LF/HF). There was no significant difference at baseline between groups. There was a decrease in LF/HF from baseline to 4 months due to a significant decrease in the yoga group (p<0.001, intra-group paired t test for repeated measures). HF, high frequency component of heart rate variability; LF, low frequency component of heart rate variability. Data are expressed as means±SD.
Heart rate variability at baseline and after 4 months for the control and yoga groups
| Variables | Control (n=13) | Yoga (n=13) | ||||
| Baseline | 4 Months | pValue | Baseline | 4 Months | pValue | |
| Variance | 1458±1399 | 1385±1343 | 0.70 | 978±797 | 910±465 | 0.57 |
| LF, ms2/Hz | 514±405 | 334±280 | 0.95 | 383±297 | 123±87 | 0.04 |
| HF, ms2/Hz | 642±676 | 496±482 | 0.88 | 431±389 | 262±206 | 0.46 |
| LF, ν | 40±13 | 41±13 | 0.81 | 40±11 | 27±8 | 0.001 |
| HF, ν | 45±14 | 45±9 | 0.53 | 47±9 | 54±15 | 0.40 |
Data are expressed as means±SD.
p<0.05 for comparisons between groups.
HF, high frequency component of heart rate variability; LF, low frequency component of heart rate variability; ν, normalised units, excluding the very low frequency component of heart rate variability.
Figure 4Individual values for overall quality of life. There was no significant difference at baseline between groups. There was a strong tendency (0.052) towards increased quality of life from baseline to 4 months, apparently due to a significant increase in the yoga group (p<0.005, intra-group paired t test for repeated measures). Bars represent means±SD.
Scores of quality of life obtained from the World Health Organization Questionnaire for Quality of Life of Elderly People (WHOQOL-OLD) at baseline and after 4 months for the control and yoga groups
| Variables | Control (n=14) | Yoga (n=15) | ||||
| Baseline | 4 Months | p Value | Baseline | 4 Months | p Value | |
| QOL | 75±9 | 76±8 | 0.6 | 77±7 | 81±6 | 0.005 |
| Autonomy | 68±15 | 71±20 | 0.3 | 69±19 | 78±10 | 0.04 |
| PPF | 73±12 | 76±15 | 0.4 | 74±7 | 79±8 | 0.01 |
| Social participation | 79±13 | 81±10 | 0.6 | 80±9 | 83±9 | 0.2 |
| DD | 76±18 | 71±18 | 0.3 | 78±17 | 81±13 | 0.2 |
| Sensorial functioning | 76±17 | 78±14 | 0.7 | 81±14 | 83±11 | 0.3 |
| Intimacy | 76±18 | 76±13 | 0.9 | 81±8 | 79±8 | 0.3 |
Data are expressed as means±SD.
p<0.05 for the comparisons between baseline and 4 months, independent of group.
DD, fear of death and dying; PPF, sense of interaction between present past and future; QOL, overall quality of life.